AllAnalyst Report
logoArgusOctober 21, 2020

Quest Diagnostics Incorporated: Upgrading to BUY ahead of 3Q results

Symbols
DGX
Sector(s)
Healthcare
Rating
Premium
Current Price
$126.00
Price Target
$NaN
Earnings Estimate
Premium
Summary

Quest Diagnostics is a leading global provider of clinical diagnostic laboratories and services that help to identify and treat disease and improve healthcare management. The company incorporated in Delaware in 1990; its predecessor companies date back to 1967. Quest is based in Madison, New Jersey and employs roughly 47,000 people.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE

Actions

Analyst Profile

Jasper Hellweg

Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology
At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing. Prior to joining Argus, Jasper worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing. He started his career at Argus in the Research department and has since widened his scope to also include becoming a regular contributor for the Market Movers and Market Digest publications, the Vickers Weekly Insider Report and Argus' bespoke research on IPOs.